+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Obstructive Sleep Apnea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768117
  • Report
  • April 2019
  • Region: Global
  • 250 pages
  • VPA Research

FEATURED COMPANIES

  • Altasciences Company Inc
  • Bioprojet SCR
  • Clinilabs Inc
  • Eisai Co Ltd
  • Jazz Pharmaceuticals Plc
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Obstructive Sleep Apnea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Obstructive Sleep Apnea. It presents in-depth analysis of Obstructive Sleep Apnea clinical trials across markets and companies. The research work is for providing complete understanding into trends in Obstructive Sleep Apnea.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Obstructive Sleep Apnea clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Obstructive Sleep Apnea

The research work is prepared through extensive and continuous research on Obstructive Sleep Apnea trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Obstructive Sleep Apnea patients are identified
  • The report includes panorama of Obstructive Sleep Apnea clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Obstructive Sleep Apnea clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Altasciences Company Inc
  • Bioprojet SCR
  • Clinilabs Inc
  • Eisai Co Ltd
  • Jazz Pharmaceuticals Plc
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Obstructive Sleep Apnea Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Obstructive Sleep Apnea Clinical Trials by Region
2.2.2 Average Enrollment of Obstructive Sleep Apnea Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Obstructive Sleep Apnea Treatment, 2019

3. Region wise Obstructive Sleep Apnea Clinical Trials
3.1 Asia Pacific Obstructive Sleep Apnea Clinical Trials by Country
3.2 Europe Obstructive Sleep Apnea Clinical Trials by Country
3.3 North America Obstructive Sleep Apnea Clinical Trials by Country
3.4 Middle East and Africa Obstructive Sleep Apnea Clinical Trials by Country
3.5 South and Central America Obstructive Sleep Apnea Clinical Trials by Country

4. Obstructive Sleep Apnea Clinical Trial Trends
4.1 Start Year wise Obstructive Sleep Apnea Clinical Trials
4.2 Phase wise Obstructive Sleep Apnea Clinical Trials
4.3 Trial Status wise Obstructive Sleep Apnea Clinical Trials
4.4 Trial Type wise Obstructive Sleep Apnea Clinical Trials

5. Obstructive Sleep Apnea Average Enrollment Trends
5.1 Average Enrollment in Obstructive Sleep Apnea Trials by Year
5.2 Average Enrollment in Obstructive Sleep Apnea Trials by Phase
5.3 Average Enrollment in Obstructive Sleep Apnea Trials by Status
5.4 Average Enrollment in Obstructive Sleep Apnea Trials by Type of Trial

6. Companies Participating in Obstructive Sleep Apnea Clinical Trials
6.1 Obstructive Sleep Apnea Trials by Sponsor Type
6.2 Obstructive Sleep Apnea Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Obstructive Sleep Apnea Trials- Phase 1
7.2 Obstructive Sleep Apnea Trials- Phase 2
7.3 Obstructive Sleep Apnea Trials- Phase 3
7.4 Obstructive Sleep Apnea Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Obstructive Sleep Apnea Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Figure 5: Europe - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Figure 7: North America - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Figure 9: Obstructive Sleep Apnea Clinical Trials by Phase
Figure 10: Obstructive Sleep Apnea Clinical Trials by Trial Status
Figure 11: Obstructive Sleep Apnea Clinical Trials by Type
Figure 12: Obstructive Sleep Apnea Clinical Trials by Sponsor Type
Figure 13: Obstructive Sleep Apnea Clinical Trials by Leading Sponsors
Figure 14: Obstructive Sleep Apnea Average Enrollment by Phase
Figure 15: Obstructive Sleep Apnea Average Enrollment by Trial Status
Figure 16: Obstructive Sleep Apnea Average Enrollment by Type
Figure 17: Obstructive Sleep Apnea- Average Enrolment by Type of Sponsors
Figure 18: Obstructive Sleep Apnea- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Obstructive Sleep Apnea Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Table 5: Europe - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Table 7: North America - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Obstructive Sleep Apnea Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Obstructive Sleep Apnea Average Enrollment by Phase
Table 15: Obstructive Sleep Apnea Average Enrollment by Trial Status
Table 16: Obstructive Sleep Apnea Average Enrollment by Type
Table 17: Obstructive Sleep Apnea- Average Enrolment by Type of Sponsors
Table 18: Obstructive Sleep Apnea- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Altasciences Company Inc
  • Bioprojet SCR
  • Clinilabs Inc
  • Eisai Co Ltd
  • Jazz Pharmaceuticals Plc
  • Merck & Co Inc
  • Mitsubishi Chemical Holdings Corp
  • RespireRx Pharmaceuticals Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Teva Pharmaceutical Ind
Note: Product cover images may vary from those shown
Adroll
adroll